A Virion-Based Combination Vaccine Protects against Influenza and SARS-CoV-2 Disease in Mice

Ryan R. Chaparian, Alfred T. Harding, Cait E. Hamele, Kristina J. Riebe, Amelia Karlsson, Gregory D. Sempowski, Nicholas S. Heaton, Brook E. Heaton

Journal of Virology · 2022 · 24 citations · 34 references

DOIFull text

Open access

Concepts

Abstract

The rapid emergence of SARS-CoV-2 variants since the onset of the pandemic has highlighted the need for both periodic vaccination "boosts" and a platform that can be rapidly reformulated to manufacture new vaccines. In this work, we report an approach that can utilize current influenza vaccine manufacturing infrastructure to generate combination vaccines capable of protecting from both influenza virus- and SARS-CoV-2-induced disease. The production of a combined influenza/SARS-CoV-2 vaccine may represent a practical solution to boost immunity to these important respiratory viruses without the increased cost and administration burden of multiple independent vaccines.

References

34